ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Anhydrous Permeation‑Enhancing Vehicle for Percutaneous Absorption of Hormones
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 228693" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.pccarx.com/products/PCCA-VERSABASE%C2%AE-ANHYDROUS-HRT/30-5056/PROPRIETARYBASES[/URL]</p><p></p><p>[ATTACH=full]23751[/ATTACH]</p><p>[ATTACH=full]23752[/ATTACH]</p><p></p><p></p><p><em><strong>VersaBase Anhydrous HRT is the pharmacy compounding industry’s first proprietary anhydrous base developed specifically to deliver female bioidentical hormones through the skin.</strong> <strong>It is also the latest addition to the VersaBase family of compounding bases that have provided patients with much-needed customized medication options for over a decade.</strong> <strong>It uses a unique, patent-pending delivery system designed to improve the solubility of lipophilic molecules, such as hormones, and is proven to increase the permeation of those molecules into and through the skin. Despite this base being an anhydrous system, these lipophilic hormones are able to partition (release) from it and into the skin.</strong></em></p><p><em><strong></strong></em></p><p><em><strong>This new base also addresses changes in the pharmacy compounding industry. Recent shifts in guidelines and standards have led to a focus on the role of water activity in establishing beyond-use dates (BUDs) for compounded medications. This, combined with the need for compounding pharmacies to maximize efficiency and control costs, is leading compounders to look for anhydrous bases to meet the needs of their patients while providing longer BUDs by default.</strong></em></p><p></p><p><strong><em>VersaBase Anhydrous HRT fulfills these needs. It has water activity below 0.6 (Aw < 0.6), which classifies it as an anhydrous base and allows for longer default BUDs according to the latest standards in pharmacy compounding. It performs exceptionally well in delivering female hormones through the skin, such as estriol, estradiol, and progesterone. It is also pleasing to the touch, offering patients elegant medications customized to their unique hormone replacement needs.</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 228693, member: 13851"] [URL unfurl="true"]https://www.pccarx.com/products/PCCA-VERSABASE%C2%AE-ANHYDROUS-HRT/30-5056/PROPRIETARYBASES[/URL] [ATTACH type="full"]23751[/ATTACH] [ATTACH type="full"]23752[/ATTACH] [I][B]VersaBase Anhydrous HRT is the pharmacy compounding industry’s first proprietary anhydrous base developed specifically to deliver female bioidentical hormones through the skin.[/B] [B]It is also the latest addition to the VersaBase family of compounding bases that have provided patients with much-needed customized medication options for over a decade.[/B] [B]It uses a unique, patent-pending delivery system designed to improve the solubility of lipophilic molecules, such as hormones, and is proven to increase the permeation of those molecules into and through the skin. Despite this base being an anhydrous system, these lipophilic hormones are able to partition (release) from it and into the skin. This new base also addresses changes in the pharmacy compounding industry. Recent shifts in guidelines and standards have led to a focus on the role of water activity in establishing beyond-use dates (BUDs) for compounded medications. This, combined with the need for compounding pharmacies to maximize efficiency and control costs, is leading compounders to look for anhydrous bases to meet the needs of their patients while providing longer BUDs by default.[/B][/I] [B][I]VersaBase Anhydrous HRT fulfills these needs. It has water activity below 0.6 (Aw < 0.6), which classifies it as an anhydrous base and allows for longer default BUDs according to the latest standards in pharmacy compounding. It performs exceptionally well in delivering female hormones through the skin, such as estriol, estradiol, and progesterone. It is also pleasing to the touch, offering patients elegant medications customized to their unique hormone replacement needs.[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Anhydrous Permeation‑Enhancing Vehicle for Percutaneous Absorption of Hormones
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top